wellrank.ai
OrderlyMeds logo

OrderlyMeds

First cited by AI Jun 12, 2026
orderlymeds.com

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning OrderlyMeds, through Jun 13, 2026.

8.3%

Avg position when mentioned: 1.0

By engine

Where OrderlyMeds is strong, and where it is invisible.

  • Perplexity
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 2 positive mentions
  • 1 neutral
  • 0 mixed or cautious

Recent AI answers mentioning OrderlyMeds

PerplexityJun 13, 2026, 11:14 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

The providers in your results that explicitly say they use licensed U.S. pharmacies are OrderlyMeds and Empower Pharmacy.[1][2] OrderlyMeds says it “exclusively works with pharmacies based in the United States,” and that medication is compounded at “U.S. based licensed pharmacies.”[1] Empower Pharmacy says it offers compounded GLP-1 injections from its 503A PCAB-accredited compounding pharmacy and that it is “licensed to ship nationwide.”[2] A few other providers in your results say they use regulated or licensed compounding pharmacies, but the wording is less specific about U.S. licensing: Fridays says its compounded GLP-1 medications are sourced from “rigorously regulated pharmacies,” but the result does not name the pharmacies or explicitly say “licensed U.S. pharmacies” on that page.[8] Henry Meds is described in the search results as using 503A or 503B compounding pharmacies, including named partners such as Belmar, Strive, Epiq Scripts, and Casa Pharma Rx, but the result does not clearly state in the excerpt that all are licensed U.S. pharmacies.[6] If you want, I can turn this into a short buyer’s comparison of these providers based on pharmacy licensing, transparency, and GLP-1 availability.

Mentioned in position 1 of 8

Read full answer with sources →
PerplexityJun 12, 2026, 10:26 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Based on the provided search results, the following compounded GLP-1 providers explicitly state that they use licensed US pharmacies (specifically citing 503A or 503B facilities based in the United States): OrderlyMeds Explicitly states they work "exclusively with pharmacies based in the United States." Lists specific US partners: SmartPharmaRx, Casa, and PerfectRx/PerfectionRx. Describes itself as a "100% online platform that connects patients to licensed healthcare professionals in all 50 states." Empower Pharmacy States their medications are made at a "503A PCAB-Accredited compounding pharmacy" (a US standard). Confirms they are licensed to "ship nationwide, including Puerto Rico," indicating a US-based operation. Henry Meds (and its partner Adonis Health Inc.) Described as "upfront" about using both 503A and 503B compounding pharmacies. Cites partner pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx (all US-based entities). Fridays Weight Loss Program (joinfridays.com) States they "deliver from 503A and 503B certified compounding pharmacies." While they do not name all partners on marketing pages, they reference Beaker Pharmacy as a fulfillment partner. The FDA clarification mentioned in the text notes that compounded semaglutide must legally come from 503A pharmacies (US standard), which Fridays claims to use. Schaffner Pharmacy Explicitly states their products are made by "FDA certified 503B compounding pharmacies," which are US-regulated facilities. Important Regulatory Context (from results): FDA Shortage Status: As of May 2025, the FDA shortages for semaglutide and tirzepatide injections have been resolved. Consequently, pharmacies are generally no longer allowed to regularly compound "essentially copies" of commercially available GLP-1s. Current Availability: Compounded versions are now largely phased out and should only be used for specific medical needs that commercial products cannot meet (e.g., non-standard doses or removing allergens). 503A vs. 503B: 503A pharmacies are traditional compounding pharmacies licensed by state boards for individual patients, while 503B facilities are outsourcing facilities regulated by the FDA. Both are US-licensed entities. Summary: The providers most clearly identified as using licensed US pharmacies are OrderlyMeds, Empower Pharmacy, Henry Meds, Fridays, and Schaffner Pharmacy. OrderlyMeds is the most explicit about its exclusive use of US-based partners.

Mentioned in position 1 of 14

Read full answer with sources →
PerplexityJun 12, 2026, 10:24 UTC
Which companies sell compounded GLP-1 weight loss medication online?

Several companies sell compounded GLP-1 weight loss medication online, including Fifty 410, OrderlyMeds, and Lemonaid Health.[1][4][5] Fifty 410 offers compounded semaglutide and tirzepatide through a fully online telehealth process and says the medications are prepared by FDA-registered 503A/503B pharmacies.[1] OrderlyMeds offers online compounded GLP-1/GIP and GLP-1 programs, with medication shipped to your door through licensed U.S. pharmacies.[4] Lemonaid Health lists compounded semaglutide and compounded tirzepatide as online weight-loss options.[5] A few related services also sell GLP-1 weight-loss medication online, but not necessarily compounded versions: GoodRx for Weight Loss offers online access to FDA-approved brand-name GLP-1s like Wegovy and Zepbound rather than compounded products.[2][3] Walgreens Weight Management similarly offers branded GLP-1 options online, including Wegovy and Zepbound.[6] If you want, I can also list these companies by price, availability by state, or whether they use semaglutide vs. tirzepatide.

Mentioned in position 2 of 5

Read full answer with sources →

Public AI visibility history

Daily rank of OrderlyMeds on our buyer intent questions, per category. A dash means the engines did not cite OrderlyMeds at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Compounded GLP-1s#32#29

TL;DR

OrderlyMeds (orderlymeds.com) is a telehealth platform focused on compounded medications, most notably compounded GLP-1 therapies for weight management. It operates as an online service connecting patients with prescribers and compounding pharmacies. According to WellRank's latest index, it ranks 14th in the Compounded GLP-1s category with 8% AI visibility, meaning it surfaces organically in roughly one in twelve AI-generated answers on that topic.

Company Overview

OrderlyMeds operates as a direct-to-consumer telehealth service built around access to compounded medications, with its most prominent category being compounded GLP-1 receptor agonists such as semaglutide and tirzepatide. Its business model connects patients seeking weight-loss treatment to licensed prescribers and partner compounding pharmacies, handling the coordination between clinical consultation and medication fulfillment. Founding details and headquarters are not publicly disclosed.

Product Features

  • Compounded semaglutide prescriptions for weight management
  • Compounded tirzepatide prescriptions for weight management
  • Online telehealth consultation and prescriber matching
  • Coordination with compounding pharmacy partners for fulfillment
  • Ongoing medication management and refill support

Target Market

OrderlyMeds primarily serves adults in the United States who are seeking affordable or accessible alternatives to brand-name GLP-1 medications for weight loss or obesity management. It is positioned for patients who may face coverage gaps, high out-of-pocket costs for branded drugs, or supply shortages, and who are comfortable with a fully digital healthcare experience.

Buyer Personas

  • A cost-conscious adult who cannot afford brand-name Wegovy or Zepbound and is looking for a compounded alternative through an online provider.
  • A busy professional who prefers managing their weight-loss prescription entirely online without in-person clinic visits.
  • A patient who has been waitlisted or priced out at a traditional obesity medicine practice and is exploring telehealth-first options.
  • A consumer who has already researched compounded GLP-1 options and is comparing providers before committing to a subscription.

Funding & Performance

Funding stage, investor backing, and financial scale are not publicly disclosed. OrderlyMeds does not appear to have announced a venture round or public filing as of the time of this profile.

Recent Developments

OrderlyMeds has gained organic traction in AI search results at a time when compounded GLP-1 medications are under significant regulatory scrutiny, with the FDA's stance on compounded semaglutide availability drawing broad industry attention as covered in sources like GoodRx's overview of compounded GLP-1 changes and GWU's public health policy tracker. The company's visibility in this window suggests it has been actively positioning itself as the regulatory landscape around compounded medications evolves. No specific product launches or partnerships have been publicly announced.

Competitive Landscape

OrderlyMeds competes in a crowded compounded GLP-1 telehealth segment. WellRank's co-mention data shows it surfaces alongside Henry Meds, Fridays, Epiq Scripts, Empower Pharmacy, Casa Pharma Rx, Walgreens Weight Management, and Strive Pharmacy in AI-generated answers. Fridays, for example, also publishes its own compounded medication information and competes directly for the same patient audience. The segment is increasingly defined by price, pharmacy credentials, and the ability to navigate evolving FDA compounding rules, as outlined in resources like the American MedSpa Association's compounded GLP-1 FAQ.

OrderlyMeds vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
OrderlyMeds logo
OrderlyMedsThis brand
#29
8.3%
Casa Pharma Rx logo
Casa Pharma Rx

2 shared answers

#35
8.3%
Empower Pharmacy logo
Empower Pharmacy

2 shared answers

#2
41.7%
Epiq Scripts logo
Epiq Scripts

2 shared answers

#34
8.3%
Fridays logo
Fridays

2 shared answers

#36
8.3%

Email me when overtakes OrderlyMeds

One email the day the ranks flip. Nothing else.

User Sentiment

Among the three AI-engine mentions tracked by WellRank, two are positive in tone and one is neutral, with no cautious or mixed characterizations recorded. This suggests that when AI assistants cite OrderlyMeds, they tend to present it as a legitimate option within the compounded GLP-1 space rather than flagging concerns. Independent consumer sentiment data is limited given the brand's early public profile, and a broader range of verified user reviews has not been publicly aggregated. Third-party roundups such as Policy Lab's semaglutide provider comparison reflect the type of coverage driving its current AI visibility.

Pricing

Pricing for OrderlyMeds services is not published in any stable, widely cited format. As is common in the compounded GLP-1 telehealth category, costs typically vary based on dosage, subscription structure, and pharmacy partner, and prospective patients are generally directed to complete an intake process before pricing is presented. Exact figures should be confirmed directly at orderlymeds.com.

Sources cited around OrderlyMeds

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track OrderlyMeds weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at OrderlyMeds? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.

OrderlyMeds: AI visibility report | WellRank